Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
NCT01009723 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2012-06-08
Summary
This protocol seeks to longitudinally collect blood samples from a cohort of pregnant women. The biological specimens will be used to determine the predictive power of biochemical markers routinely used in Down syndrome screening in the assessment of patient's risk of preterm delivery.
Conditions
- Preterm Delivery
Sponsors & Collaborators
-
Esoterix Genetic Laboratories, LLC
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Esoterix Genetic Laboratories, LLC
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- United States
Study Locations
More Related Trials
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Protein and Ultrasound Indicators of Preterm Birth
NCT01412931 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Biomarkers in Obstetrical Complications
NCT03480139 ·Status: COMPLETED
-
Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition
NCT00342277 ·Status: COMPLETED
-
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Prediction of the Onset of Term and Preterm Labour
NCT04590677 ·Status: UNKNOWN
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood
NCT01472523 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Whole Blood Specimen Collection From Pregnant Subjects
NCT02430584 ·Status: UNKNOWN
-
Establishing First Trimester Markers for the Identification of High Risk Twin
NCT02031393 ·Status: UNKNOWN
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
NCT01837979 ·Status: UNKNOWN
-
Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)
NCT05076734 ·Status: COMPLETED ·Phase: NA
-
Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)
NCT03530332 ·Status: TERMINATED ·Phase: NA